Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole vs Bromocriptine in Advanced Parkinson's Disease
NCT02172573Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 1999
- Primary completion
- Jul 2000
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of pramipexole in Parkinson's disease (PD), sponsored by Boehringer Ingelheim. Started Apr 1999; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02172573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172573.